Skip to main content

XORTX Therapeutics Inc.

corporate_fare Company Profile

XORTX Therapeutics Inc.

XRTX·NASDAQ·Life Sciences·CIK 0001729214

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing and commercializing treatments for diseases linked to high uric acid levels in Canada. The company is developing several therapies: XRx-026, which is in Phase III clinical trials for treating gout; XRx-008, currently in Phase II for autosomal dominant polycystic kidney disease; and XRx-101, also in Phase II, for acute kidney injury resulting from respiratory virus infections, including sepsis and coronavirus. Additionally, XRX-225 is in the preclinical stage for treating type 2 diabetic nephropathy. XORTX Therapeutics Inc. also has a program called VB4-P5, which aims to treat and prevent kidney fibrosis. The company operates from Calgary, Canada.

XORTX Therapeutics Inc. (NASDAQ:XRTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for XRTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-14, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for XRTX spans 6-K, 424B4, 20-F.

Recent high-impact activity:

  • XORTX Q3 Interim Report: Going-Concern Warning, $318,846 Cash, Material Weakness Persists
  • XORTX Adds Health Canada CTA Filing to Gout Program, Accelerating Global Regulatory Push
  • XORTX Sets Q4 2026 FDA IND Submission for Gout Drug XORLO™, Targets NDA in About a Year
  • XORTX Targets Q4 FDA Filing for Gout Drug, Sees $700M Market
  • XORTX Re-Engages IR Agency with $2.5M Non-Refundable Fee After Delisting

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$2.66M
Diluted EPS
-$0.56
Op. Cash Flow
-$2.77M
Cash & Equivalents
$864.51K
Debt / Equity
0.00×
Shares Outstanding
6.96M sh
Source: 20-F · filed 2026-03-20 · accession 0001104659-26-032775

Short Interest & Short Volume

2.10 days to cover

FINRA reported short interest of 122,511 shares in XRTX as of the October 30, 2026 settlement, a 48.3% decrease from the prior period — about 2.1 days to cover at its recent average daily volume. On November 20, 2026, 43.5% of XRTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)122,511 shares as of October 30, 2026
Change vs prior period▼ 48.3%
Days to cover2.10 at avg daily volume of 58,359
Daily short volume (FINRA facilities)43.5% of 28,343 shares on November 20, 2026
5-day average short volume55.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

XRTX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with X →
$0.839
52-week range · as of 2026-11-14 $0.8151 – $3.6
Market cap
$1.88M
Volume
47.9K (0.2× avg)
3-mo avg 211.1K
Live data · 2026-11-22 12:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XRTX - Latest Insights

XRTX
Nov 13, 2026, 9:21 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.839 info
Change: -$0.172 (-17%) info
Market Cap: $1.885M info
XRTX
Oct 08, 2026, 4:00 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.33
Real-time Price: $0.839 info
Change: -$1.49 (-64%) info
Market Cap: $1.885M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.76
Real-time Price: $0.839 info
Change: -$0.9254 (-52%) info
Market Cap: $1.885M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $0.839 info
Change: -$0.841 (-50%) info
Market Cap: $1.885M info
XRTX
Sep 04, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.39
Real-time Price: $0.839 info
Change: -$1.55 (-65%) info
Market Cap: $1.885M info
XRTX
Aug 28, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.44
Real-time Price: $0.839 info
Change: -$1.60 (-66%) info
Market Cap: $1.885M info
XRTX
Aug 17, 2026, 6:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.19
Real-time Price: $0.839 info
Change: -$1.35 (-62%) info
Market Cap: $1.885M info
XRTX
Jun 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.06
Real-time Price: $0.839 info
Change: -$1.22 (-59%) info
Market Cap: $1.885M info
XRTX
Jun 12, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $0.839 info
Change: -$1.34 (-62%) info
Market Cap: $1.885M info
XRTX
May 19, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.53
Real-time Price: $0.839 info
Change: -$1.69 (-67%) info
Market Cap: $1.885M info
XRTX
May 19, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.53
Real-time Price: $0.839 info
Change: -$1.69 (-67%) info
Market Cap: $1.885M info
XRTX
May 15, 2026, 10:29 AM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $2.60
Real-time Price: $0.839 info
Change: -$1.76 (-68%) info
Market Cap: $1.885M info
XRTX
May 14, 2026, 9:09 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $0.839 info
Change: -$1.20 (-59%) info
Market Cap: $1.885M info
XRTX
May 08, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.79
Real-time Price: $0.839 info
Change: -$1.95 (-70%) info
Market Cap: $1.885M info
XRTX
Apr 21, 2026, 10:07 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.98
Real-time Price: $0.839 info
Change: -$2.14 (-72%) info
Market Cap: $1.885M info
XRTX
Apr 13, 2026, 5:00 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $0.839 info
Change: -$2.59 (-76%) info
Market Cap: $1.885M info
XRTX
Mar 26, 2026, 5:44 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.400
Real-time Price: $0.839 info
Change: Reverse Stock Split info
Market Cap: $1.885M info
XRTX
Mar 25, 2026, 8:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.340
Real-time Price: $0.839 info
Change: Reverse Stock Split info
Market Cap: $1.885M info
XRTX
Mar 24, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.3611
Real-time Price: $0.839 info
Change: Reverse Stock Split info
Market Cap: $1.885M info
XRTX
Mar 20, 2026, 5:00 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.389
Real-time Price: $0.839 info
Change: Reverse Stock Split info
Market Cap: $1.885M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets